Also, we have demonstrated that eEF2 was overexpressed in the majority of gastric and colorectal cancers and promoted progression of G2/M in the cell cycle, resulting in the enhancement of in vitro and in vivo cancer cell growth (14). Here, EEF2 is linked to colorectal cancer.